Balance Sheet Kikkoman Corporation

Equities

2801

JP3240400006

Food Processing

Market Closed - Japan Exchange Other stock markets 12:00:00 05/06/2026 pm IST			5-day change	1st Jan Change
1,437.00 ^JPY	-0.90%		+3.16%	+1.05%

25/04	Kikkoman Corporation Reports Earnings Results for the Full Year Ended March 31, 2026	CI
24/04	Kikkoman's Profit Slips Marginally in Fiscal Year 2026	MT

e43d4d2b3.SOzoA7O9xmobBuLX3UwioMDsLm9CBcWET7GlDt1H98E.AqScMMLfhSJINLaWkAtQxqWPdjAyYY7bGsDoZYsPoYUmma5N683xXyM10g

Published financial data: KIKKOMAN CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	44TCr	52TCr	62TCr	66TCr	71TCr
Total Revenues	44TCr	52TCr	62TCr	66TCr	71TCr
Cost of Goods Sold, Total	29TCr	34TCr	41TCr	43TCr	47TCr
Gross Profit	15TCr	18TCr	20TCr	23TCr	24TCr
Selling General & Admin Expenses, Total	9.93TCr	11TCr	13TCr	14TCr	15TCr
Provision for Bad Debts	-	-	-	-	-
R&D Expenses	475.8Cr	489.2Cr	517.4Cr	506.7Cr	536.2Cr
Depreciation & Amortization - (IS)	754.5Cr	781.3Cr	878.3Cr	970.6Cr	1.14TCr
Other Operating Expenses	-46Cr	238.2Cr	89Cr	370.2Cr	54Cr
Other Operating Expenses, Total	11TCr	13TCr	15TCr	16TCr	16TCr
Operating Income	4.31TCr	4.99TCr	5.79TCr	6.97TCr	7.67TCr
Interest Expense, Total	-92Cr	-74Cr	-100Cr	-149Cr	-173Cr
Interest And Investment Income	111.5Cr	116.8Cr	269.9Cr	511Cr	649Cr
Net Interest Expenses	20Cr	43Cr	170.4Cr	362Cr	476Cr
Income (Loss) On Equity Invest.	21Cr	25Cr	25Cr	26Cr	43Cr
Currency Exchange Gains (Loss)	-122.5Cr	-570.3Cr	-632.8Cr	-740.1Cr	130.2Cr
Other Non Operating Income (Expenses)	17Cr	-22Cr	-14Cr	-31Cr	18Cr
EBT, Excl. Unusual Items	4.25TCr	4.46TCr	5.34TCr	6.59TCr	8.34TCr
Gain (Loss) On Sale Of Investments	-	217.2Cr	-	-200.5Cr	-
Gain (Loss) On Sale Of Assets	-98Cr	-49Cr	-77Cr	-40Cr	-115.2Cr
Asset Writedown	171.8Cr	790.1Cr	819.1Cr	1.21TCr	149.7Cr
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	4.32TCr	5.42TCr	6.08TCr	7.56TCr	8.38TCr
Income Tax Expense	1.16TCr	1.49TCr	1.66TCr	1.87TCr	2.16TCr
Earnings From Continuing Operations	3.16TCr	3.93TCr	4.42TCr	5.69TCr	6.22TCr
Net Income to Company	3.16TCr	3.93TCr	4.42TCr	5.69TCr	6.22TCr
Minority Interest	-46Cr	-44Cr	-47Cr	-46Cr	-49Cr
Net Income - (IS)	3.12TCr	3.89TCr	4.37TCr	5.64TCr	6.17TCr
Net Income to Common Incl Extra Items	3.12TCr	3.89TCr	4.37TCr	5.64TCr	6.17TCr
Net Income to Common Excl. Extra Items	3.12TCr	3.89TCr	4.37TCr	5.64TCr	6.17TCr
Per Share Items
Net EPS - Basic	32.46	40.59	45.67	59.19	64.99
Basic EPS - Continuing Operations	32.46	40.59	45.67	59.19	64.99
Basic Weighted Average Shares Outstanding	96Cr	96Cr	96Cr	95Cr	95Cr
Net EPS - Diluted	32.46	40.59	45.67	59.19	64.99
Diluted EPS - Continuing Operations	32.46	40.59	45.67	59.19	64.99
Diluted Weighted Average Shares Outstanding	96Cr	96Cr	96Cr	95Cr	95Cr
Normalized Basic EPS	27.16	28.65	34.35	42.7	54.4
Normalized Diluted EPS	27.16	28.65	34.35	42.7	54.4
Dividend Per Share	9	12.2	13.6	20.8	23
Payout Ratio	25.88	22.68	30.23	27.77	37.04
American Depositary Receipts Ratio (ADR)	2	2	2	2	2
Supplemental Items
EBITDA	6.23TCr	6.99TCr	8.01TCr	9.37TCr	10TCr
EBITA	4.31TCr	4.99TCr	5.79TCr	6.97TCr	7.67TCr
EBIT	4.31TCr	4.99TCr	5.79TCr	6.97TCr	7.67TCr
Effective Tax Rate - (Ratio)	26.79	27.45	27.3	24.74	25.75
Normalized Net Income	2.61TCr	2.75TCr	3.29TCr	4.07TCr	5.16TCr
Non-Cash Pension Expense	132.2Cr	527Cr	570.9Cr	457.1Cr	394.6Cr
Supplemental Operating Expense Items
Advertising Expense	1.44TCr	1.46TCr	1.47TCr	1.78TCr	1.75TCr
Selling and Marketing Expenses	3.85TCr	4.27TCr	4.61TCr	4.88TCr	5.04TCr
Research And Development Expense From Footnotes	475.8Cr	489.2Cr	517.4Cr	506.7Cr	536.2Cr

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	5.57TCr	7.92TCr	9.93TCr	12TCr	11TCr
Short Term Investments	-	-	-	-	-
Total Cash And Short Term Investments	5.57TCr	7.92TCr	9.93TCr	12TCr	11TCr
Accounts Receivable, Total	6.26TCr	6.94TCr	7.51TCr	8.38TCr	8.26TCr
Total Receivables	6.26TCr	6.94TCr	7.51TCr	8.38TCr	8.26TCr
Inventory	6.31TCr	8.27TCr	9.22TCr	9.5TCr	10TCr
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	1.1TCr	885.6Cr	1.46TCr	4.45TCr	4.12TCr
Total Current Assets	19TCr	24TCr	28TCr	34TCr	33TCr
Net Property Plant And Equipment	15TCr	16TCr	18TCr	21TCr	23TCr
Long-term Investments	8.38TCr	9.02TCr	9.15TCr	10TCr	11TCr
Goodwill	500.6Cr	462.6Cr	465.7Cr	340.3Cr	319.6Cr
Other Intangibles, Total	507.5Cr	494.7Cr	479.5Cr	496.5Cr	493.4Cr
Loans Receivable Long-Term	-	-	-	-	-
Deferred Tax Assets Long-Term	300.5Cr	343.1Cr	305.8Cr	269.5Cr	304.9Cr
Other Long-Term Assets, Total	50L	60L	60L	50L	40L
Total Assets	44TCr	50TCr	57TCr	67TCr	68TCr
Liabilities
Accounts Payable, Total	5.06TCr	5.96TCr	6.13TCr	6.51TCr	6.06TCr
Accrued Expenses, Total	-	-	-	-	-
Short-term Borrowings	374.7Cr	410.3Cr	405.4Cr	377.3Cr	384.2Cr
Current Portion of Long-Term Debt	20Cr	40Cr	1.3TCr	-	-
Current Portion of Leases	496.7Cr	431.3Cr	515.8Cr	697.5Cr	679.1Cr
Current Income Taxes Payable	421Cr	518.2Cr	263.9Cr	421.8Cr	293.7Cr
Other Current Liabilities	897Cr	965.4Cr	1.26TCr	1.5TCr	1.38TCr
Total Current Liabilities	7.27TCr	8.32TCr	9.88TCr	9.51TCr	8.81TCr
Long-Term Debt	1.34TCr	1.3TCr	40Cr	1.44TCr	1.44TCr
Long-Term Leases	1.93TCr	2.16TCr	2.84TCr	3.48TCr	3.4TCr
Pension & Other Post Retirement Benefits	504.7Cr	532.2Cr	465.8Cr	372.8Cr	345.5Cr
Deferred Tax Liability Non Current	852.9Cr	875.4Cr	1.01TCr	1.31TCr	1.47TCr
Other Non Current Liabilities	597.6Cr	721Cr	718.1Cr	860.3Cr	880.5Cr
Total Liabilities	12TCr	14TCr	15TCr	17TCr	16TCr
Common Stock, Total	1.16TCr	1.16TCr	1.16TCr	1.16TCr	1.16TCr
Additional Paid In Capital	1.37TCr	1.37TCr	1.37TCr	1.39TCr	1.39TCr
Retained Earnings	27TCr	30TCr	33TCr	38TCr	42TCr
Treasury Stock	-365.8Cr	-680.8Cr	-732.6Cr	-1.7TCr	-3.18TCr
Comprehensive Income and Other	1.94TCr	4.22TCr	6.3TCr	11TCr	9.97TCr
Total Common Equity	31TCr	36TCr	41TCr	49TCr	51TCr
Minority Interest	538.4Cr	609.1Cr	645.6Cr	689.9Cr	751Cr
Total Equity	31TCr	36TCr	42TCr	50TCr	52TCr
Total Liabilities And Equity	44TCr	50TCr	57TCr	67TCr	68TCr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	96Cr	96Cr	96Cr	95Cr	94Cr
ECS Total Common Shares Outstanding	96Cr	96Cr	96Cr	-	94Cr
Book Value / Share	321.02	373.63	428.78	516.42	539.54
Tangible Book Value	30TCr	35TCr	40TCr	48TCr	50TCr
Tangible Book Value Per Share	310.51	363.63	418.91	507.62	530.92
Total Debt	4.17TCr	4.35TCr	5.1TCr	5.99TCr	5.9TCr
Net Debt	-1.4TCr	-3.58TCr	-4.84TCr	-5.92TCr	-4.72TCr
Debt Equivalent of Unfunded Proj. Benefit Obligation	-239.3Cr	-250.2Cr	-352Cr	-986.2Cr	-1.26TCr
Minority Interest, Total (Incl. Fin. Div)	538.4Cr	609.1Cr	645.6Cr	689.9Cr	751Cr
Equity Method Investments, Total	354.5Cr	393.9Cr	424.8Cr	532.6Cr	628.7Cr
Inventories - Raw Materials, Total	597Cr	737.5Cr	878.8Cr	696.9Cr	715.5Cr
Inventories - Work In Process, Total	1.17TCr	1.29TCr	1.6TCr	1.69TCr	1.61TCr
Inventories - Finished Goods, Total	4.54TCr	6.24TCr	6.75TCr	7.11TCr	8.16TCr
Inventories - Others	10L	20L	10L	-	10L
Full Time Employees	7.64T	7.69T	7.78T	7.52T	7.72T
Accumulated Allowance for Doubtful Accounts (Supple)	66Cr	49Cr	54Cr	59Cr	65Cr

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	4.32TCr	5.42TCr	6.08TCr	7.56TCr	8.38TCr
Depreciation & Amortization - CF	1.92TCr	2TCr	2.22TCr	2.4TCr	2.69TCr
Depreciation & Amortization, Total	1.92TCr	2TCr	2.22TCr	2.4TCr	2.69TCr
(Gain) Loss From Sale Of Asset	216Cr	147.1Cr	176.8Cr	40Cr	308.3Cr
(Gain) Loss on Sale of Investments - (CF)	-	-217.2Cr	-	-	-
(Income) Loss On Equity Investments - (CF)	-21Cr	-25Cr	-25Cr	-26Cr	-43Cr
Other Operating Activities, Total	-1.02TCr	-1.53TCr	-1.98TCr	-1.91TCr	-2.22TCr
Change In Accounts Receivable	135.5Cr	-394.8Cr	-238.4Cr	-327Cr	41Cr
Change In Inventories	53Cr	-1.45TCr	-502Cr	-143.6Cr	-1.09TCr
Change In Accounts Payable	171Cr	496.6Cr	-206.8Cr	-294.9Cr	-316.6Cr
Change in Other Net Operating Assets	-62Cr	752.2Cr	391.1Cr	781.4Cr	-342.8Cr
Cash from Operations	5.72TCr	5.21TCr	5.92TCr	8.08TCr	7.4TCr
Capital Expenditure	-1.57TCr	-1.87TCr	-2.56TCr	-2.97TCr	-3.95TCr
Sale of Property, Plant, and Equipment	27Cr	20Cr	10Cr	9.3Cr	5.9Cr
Cash Acquisitions	-	-	-	-	-
Divestitures	-	367.1Cr	-	-	-
Sale (Purchase) of Intangible assets	-132.5Cr	-87Cr	-95Cr	-136Cr	-118.2Cr
Investment in Marketable and Equity Securities, Total	-81Cr	-172.2Cr	-93Cr	-1.92TCr	153.7Cr
Net (Increase) Decrease in Loans Originated / Sold - Investing	5.2Cr	-15Cr	-5.2Cr	-11Cr	-54Cr
Other Investing Activities, Total	64Cr	145.6Cr	80Cr	729.2Cr	115.3Cr
Cash from Investing	-1.69TCr	-1.61TCr	-2.66TCr	-4.3TCr	-3.85TCr
Short Term Debt Issued, Total	-	24Cr	-	-	3.2Cr
Long-Term Debt Issued, Total	-	-	40Cr	1.4TCr	-
Total Debt Issued	-	24Cr	40Cr	1.4TCr	3.2Cr
Short Term Debt Repaid, Total	-158.1Cr	-	-14Cr	-32Cr	-
Long-Term Debt Repaid, Total	-	-20Cr	-40Cr	-1.3TCr	-
Total Debt Repaid	-158.1Cr	-20Cr	-54Cr	-1.33TCr	-
Repurchase of Common Stock	-3.3Cr	-315.4Cr	-52Cr	-969.1Cr	-1.52TCr
Common Dividends Paid	-806.5Cr	-882.5Cr	-1.32TCr	-1.57TCr	-2.29TCr
Common & Preferred Stock Dividends Paid	-806.5Cr	-882.5Cr	-1.32TCr	-1.57TCr	-2.29TCr
Other Financing Activities, Total	-574.1Cr	-595.5Cr	-649.5Cr	-673.5Cr	-806.1Cr
Cash from Financing	-1.54TCr	-1.79TCr	-2.04TCr	-3.14TCr	-4.61TCr
Foreign Exchange Rate Adjustments	271.4Cr	546.4Cr	792Cr	1.34TCr	-241.1Cr
Miscellaneous Cash Flow Adjustments	-10L	-10L	-	-10L	-
Net Change in Cash	2.76TCr	2.36TCr	2.01TCr	1.98TCr	-1.3TCr
Supplemental Items
Cash Interest Paid	93Cr	74Cr	100.7Cr	146.9Cr	173.2Cr
Cash Income Tax Paid (Refund)	1.02TCr	1.53TCr	1.96TCr	1.94TCr	2.2TCr
Levered Free Cash Flow	3.11TCr	1.75TCr	1.25TCr	191.09Cr	2.09TCr
Unlevered Free Cash Flow	3.17TCr	1.8TCr	1.31TCr	284.21Cr	2.2TCr
Change In Net Working Capital	-252.1Cr	1.37TCr	1.88TCr	3.37TCr	1.22TCr
Net Debt Issued / Repaid	-158.1Cr	3.4Cr	-14Cr	68Cr	3.2Cr

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	6.52	6.62	6.77	7.06	7.12
Return on Total Capital	8.06	8.18	8.27	8.49	8.46
Return On Equity %	10.7	11.62	11.32	12.43	12.26
Return on Common Equity	10.73	11.68	11.38	12.52	12.34
Margin Analysis
Gross Profit Margin %	35.1	34.63	33.03	34.61	33.74
SG&A Margin	22.59	22.05	21.28	21.27	20.47
EBITDA Margin %	14.19	13.54	12.95	14.18	14.62
EBITA Margin %	9.81	9.66	9.35	10.55	10.82
EBIT Margin %	9.81	9.66	9.35	10.55	10.82
Income From Continuing Operations Margin %	7.2	7.62	7.14	8.61	8.77
Net Income Margin %	7.09	7.53	7.07	8.54	8.7
Net Avail. For Common Margin %	7.09	7.53	7.07	8.54	8.7
Normalized Net Income Margin	5.93	5.32	5.32	6.16	7.28
Levered Free Cash Flow Margin	7.07	3.39	2.02	0.29	2.94
Unlevered Free Cash Flow Margin	7.2	3.48	2.12	0.43	3.1
Asset Turnover
Asset Turnover	1.06	1.1	1.16	1.07	1.05
Fixed Assets Turnover	2.95	3.34	3.63	3.38	3.25
Receivables Turnover (Average Receivables)	7.17	7.83	8.57	8.32	8.52
Inventory Turnover (Average Inventory)	4.6	4.63	4.74	4.62	4.7
Short Term Liquidity
Current Ratio	2.65	2.89	2.85	3.6	3.8
Quick Ratio	1.63	1.79	1.77	2.14	2.14
Operating Cash Flow to Current Liabilities	0.79	0.63	0.6	0.85	0.84
Days Sales Outstanding (Average Receivables)	50.89	46.64	42.6	44	42.83
Days Outstanding Inventory (Average Inventory)	79.38	78.81	77.02	79.28	77.65
Average Days Payable Outstanding	47.01	56.29	52.04	53.19	47.83
Cash Conversion Cycle (Average Days)	83.26	69.16	67.58	70.09	72.66
Long Term Solvency
Total Debt/Equity	13.29	11.94	12.23	12.02	11.44
Total Debt / Total Capital	11.73	10.67	10.89	10.73	10.26
LT Debt/Equity	10.44	9.52	6.9	9.87	9.38
Long-Term Debt / Total Capital	9.22	8.5	6.15	8.81	8.41
Total Liabilities / Total Assets	28.5	27.66	26.38	25.4	24.04
EBIT / Interest Expense	46.91	67.7	58.18	46.78	44.35
EBITDA / Interest Expense	67.84	94.87	80.53	62.9	59.91
(EBITDA - Capex) / Interest Expense	50.73	69.5	54.81	42.97	37.09
Total Debt / EBITDA	0.67	0.62	0.64	0.64	0.57
Net Debt / EBITDA	-0.22	-0.51	-0.6	-0.63	-0.46
Total Debt / (EBITDA - Capex)	0.89	0.85	0.93	0.94	0.92
Net Debt / (EBITDA - Capex)	-0.3	-0.7	-0.89	-0.93	-0.74
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-6.23	17.53	19.84	6.78	7.29
Gross Profit, 1 Yr. Growth %	-15.09	15.95	14.31	11.88	4.6
EBITDA, 1 Yr. Growth %	12.1	12.16	14.6	16.96	10.59
EBITA, 1 Yr. Growth %	11.02	15.74	16.03	20.4	10.09
EBIT, 1 Yr. Growth %	11.02	15.74	16.03	20.4	10.09
Earnings From Cont. Operations, 1 Yr. Growth %	17.1	24.42	12.34	28.73	9.29
Net Income, 1 Yr. Growth %	17.16	24.85	12.42	29.06	9.31
Normalized Net Income, 1 Yr. Growth %	9.85	5.34	19.78	23.76	26.85
Diluted EPS Before Extra, 1 Yr. Growth %	17.16	25.03	12.53	29.6	9.79
Accounts Receivable, 1 Yr. Growth %	4.38	10.91	8.16	11.66	-1.48
Inventory, 1 Yr. Growth %	3.5	31.09	11.51	2.98	10.45
Net Property, Plant and Equip., 1 Yr. Growth %	0.1	7.01	13.46	16.04	7.56
Total Assets, 1 Yr. Growth %	13.21	14.72	12.59	17.92	1.73
Tangible Book Value, 1 Yr. Growth %	13.21	16.84	15.17	20.43	3.61
Common Equity, 1 Yr. Growth %	13.1	16.12	14.73	19.69	3.5
Cash From Operations, 1 Yr. Growth %	44.16	-8.88	13.64	36.51	-8.45
Capital Expenditures, 1 Yr. Growth %	-36.62	18.95	36.89	16.05	32.94
Levered Free Cash Flow, 1 Yr. Growth %	138.2	-43.62	-28.73	-84.7	992.58
Unlevered Free Cash Flow, 1 Yr. Growth %	137.33	-43.19	-27.09	-78.32	672.63
Dividend Per Share, 1 Yr. Growth %	7.14	35.56	11.48	52.94	10.58
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-1.57	4.98	18.68	13.12	7.03
Gross Profit, 2 Yr. CAGR %	-6.32	-0.78	15.13	13.09	8.18
EBITDA, 2 Yr. CAGR %	10.76	12.13	13.37	15.77	13.73
EBITA, 2 Yr. CAGR %	7.14	13.36	15.89	18.2	15.13
EBIT, 2 Yr. CAGR %	7.14	13.36	15.89	18.2	15.13
Earnings From Cont. Operations, 2 Yr. CAGR %	9.44	20.7	18.23	20.26	18.61
Net Income, 2 Yr. CAGR %	9.49	20.95	18.47	20.45	18.77
Normalized Net Income, 2 Yr. CAGR %	11.34	7.57	12.33	21.75	25.29
Diluted EPS Before Extra, 2 Yr. CAGR %	9.49	21.03	18.62	20.77	19.28
Accounts Receivable, 2 Yr. CAGR %	2.12	7.6	9.53	9.89	4.89
Inventory, 2 Yr. CAGR %	3.54	16.48	20.91	7.16	6.65
Net Property, Plant and Equip., 2 Yr. CAGR %	9.97	3.5	10.19	14.74	11.72
Total Assets, 2 Yr. CAGR %	10.04	13.96	13.65	15.22	9.52
Tangible Book Value, 2 Yr. CAGR %	8.09	15.01	16	17.77	11.7
Common Equity, 2 Yr. CAGR %	7.74	14.6	15.42	17.18	11.3
Cash From Operations, 2 Yr. CAGR %	24.26	14.62	1.76	24.55	11.79
Capital Expenditures, 2 Yr. CAGR %	-23.11	-13.17	27.61	26.04	24.21
Levered Free Cash Flow, 2 Yr. CAGR %	152.15	15.88	-36.61	-66.98	29.3
Unlevered Free Cash Flow, 2 Yr. CAGR %	152.36	16.11	-35.64	-60.24	29.42
Dividend Per Share, 2 Yr. CAGR %	4.76	20.51	22.93	30.57	30.05
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	0.68	4.42	9.72	14.57	11.14
Gross Profit, 3 Yr. CAGR %	-3.23	0.58	4.02	14.04	10.19
EBITDA, 3 Yr. CAGR %	7.87	11.23	12.95	14.56	14.02
EBITA, 3 Yr. CAGR %	5.7	9.93	14.24	17.37	15.43
EBIT, 3 Yr. CAGR %	5.7	9.93	14.24	17.37	15.43
Earnings From Cont. Operations, 3 Yr. CAGR %	9.39	14.22	17.85	21.63	16.48
Net Income, 3 Yr. CAGR %	9.33	14.39	18.03	21.9	16.62
Normalized Net Income, 3 Yr. CAGR %	3.47	9.3	11.5	16.02	23.43
Diluted EPS Before Extra, 3 Yr. CAGR %	9.48	14.44	18.13	22.17	16.99
Accounts Receivable, 3 Yr. CAGR %	2.59	4.97	7.78	10.23	5.97
Inventory, 3 Yr. CAGR %	5.55	12.02	14.8	14.61	8.25
Net Property, Plant and Equip., 3 Yr. CAGR %	10.66	8.97	6.72	12.1	12.3
Total Assets, 3 Yr. CAGR %	8.12	11.58	13.5	15.06	10.54
Tangible Book Value, 3 Yr. CAGR %	7.86	10.93	15.06	17.46	12.84
Common Equity, 3 Yr. CAGR %	7.49	10.47	14.65	16.83	12.43
Cash From Operations, 3 Yr. CAGR %	14.94	12.06	14.29	12.23	12.4
Capital Expenditures, 3 Yr. CAGR %	-1.39	-11.07	1.06	23.63	28.3
Levered Free Cash Flow, 3 Yr. CAGR %	14.61	53.04	-1.45	-60.53	6.02
Unlevered Free Cash Flow, 3 Yr. CAGR %	14.96	53.51	-0.57	-55.22	6.89
Dividend Per Share, 3 Yr. CAGR %	9.79	14.16	17.42	32.21	23.53
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	1.48	5.13	7.52	7.82	8.63
Gross Profit, 5 Yr. CAGR %	-0.75	2.27	3.74	5.41	5.66
EBITDA, 5 Yr. CAGR %	6.96	9.13	10.04	13.02	13.26
EBITA, 5 Yr. CAGR %	5.75	8.72	9.66	13.16	14.6
EBIT, 5 Yr. CAGR %	5.75	8.72	9.66	13.16	14.6
Earnings From Cont. Operations, 5 Yr. CAGR %	9.41	10.52	12.84	16.6	18.15
Net Income, 5 Yr. CAGR %	9.31	10.32	12.9	16.78	18.33
Normalized Net Income, 5 Yr. CAGR %	4.49	6.58	6.93	14.12	16.82
Diluted EPS Before Extra, 5 Yr. CAGR %	9.59	10.48	13.04	16.93	18.59
Accounts Receivable, 5 Yr. CAGR %	3.96	4.98	5.31	6.91	6.61
Inventory, 5 Yr. CAGR %	5.42	10.76	11.45	10.05	11.47
Net Property, Plant and Equip., 5 Yr. CAGR %	7.29	8.47	10.47	11.25	8.69
Total Assets, 5 Yr. CAGR %	3.7	6.85	10.3	13.02	11.9
Tangible Book Value, 5 Yr. CAGR %	7.55	8.8	11.04	13.62	13.71
Common Equity, 5 Yr. CAGR %	6.62	8.31	10.6	13.11	13.3
Cash From Operations, 5 Yr. CAGR %	8.71	14.79	9.48	16.89	13.28
Capital Expenditures, 5 Yr. CAGR %	3.85	11.25	9.32	2.24	9.75
Levered Free Cash Flow, 5 Yr. CAGR %	2.27	15.98	-9.57	-17.13	9.86
Unlevered Free Cash Flow, 5 Yr. CAGR %	2.16	15.29	-8.85	-10.58	10.49
Dividend Per Share, 5 Yr. CAGR %	7.06	12.4	14.87	20.46	22.32